Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Spironolactone First, Then Amiloride	0	13
Total, all-cause mortality	Amiloride First, Then Spironolactone	0	6
Total, all-cause mortality	Spironolactone Second Intervention	0	6
Total, all-cause mortality	Amiloride Second Intervention	0	12
Total, other adverse events	Spironolactone First, Then Amiloride	0	13
Total, other adverse events	Amiloride First, Then Spironolactone	0	6
Total, other adverse events	Spironolactone Second Intervention	1	6
Total, other adverse events	Amiloride Second Intervention	0	12
Total, serious adverse events	Spironolactone First, Then Amiloride	0	13
Total, serious adverse events	Amiloride First, Then Spironolactone	0	6
Total, serious adverse events	Spironolactone Second Intervention	0	6
Total, serious adverse events	Amiloride Second Intervention	0	12

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02497300/event-totals